BOT:ASX
Botanix Pharmaceuticals Ltd
0,020Â AUD
arrow_upward
+11,11%(+0,0020) 1 d
18 sep., 16:10:25 GMT+10 · AUD
search
Alla symboler
1 d
5 d
1 m
6 m
Hittills i år
1 år
5 år
MAX
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för BOT …
Öppen
0,02Â AUD
Högt
0,02Â AUD
LÃ¥gt
0,02Â AUD
Börsvärde
49,26Â mn
Genomsn. vol.
5,65Â mn
Volym
4,07Â mn
52v högst
0,17Â AUD
52v lägst
0,02Â AUD
EPS
−0,03 AUD
Utestående aktier
2,74Â md
Antal anställda
11
Öppen
0,02Â AUD
Högt
0,02Â AUD
LÃ¥gt
0,02Â AUD
Börsvärde
49,26Â mn
Genomsn. vol.
5,65Â mn
Volym
4,07Â mn
52v högst
0,17Â AUD
52v lägst
0,02Â AUD
EPS
−0,03 AUD
Utestående aktier
2,74Â md
Antal anställda
11
Profil
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Om Botanix Pharmaceuticals Ltd